PhotoCure ASA (FRA:PHS)
€ 4.135 0.01 (0.24%) Market Cap: 114.24 Mil Enterprise Value: 89.30 Mil PE Ratio: 93.08 PB Ratio: 2.63 GF Score: 78/100

Q3 2021 Photocure ASA Earnings Call Transcript

Nov 17, 2021 / 01:00PM GMT
Release Date Price: €11.79 (-2.00%)
Daniel Schneider
Photocure ASA - President & CEO

Well, good afternoon to those in Europe. Good morning. This is Dan Schneider, CEO of Photocure. With me today is Erik Dahl, CFO, and we're proud to present the results for the third quarter of 2021.

Next slide. Just a reminder, today's disclaimers are in place.

Third slide. So I believe we delivered another productive quarter in the shadows of COVID. We've shown growth. We continue to generate data on the advantages of using blue light cystoscopy. We strengthened partnerships and entered new markets like Canada, and we ended the quarter with a strong balance sheet.

Keep in mind, a couple of important factors. Last year's Q3 was a catch-up quarter for postponed procedures in quarter two. So we're up against an inordinate amount of backlog that hit Q3 last year. And this year, we dealt with the onslaught of the delta variant as we got into Q3. However, we did show growth in many markets like the U.S., France, Italy, U.K. and held tight on some of the other markets like Germany. We are essentially breakeven and demonstrated

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot